Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study

This study will validate a previously developed pediatric prognostic biomarker algorithm
aimed at improving prediction of risk for the later development of chronic graft-versus-host
disease (cGvHD) in children and young adults undergoing allogeneic hematopoietic stem cell
transplant.

By developing an early risk stratification of patients into low-, intermediate-, and
high-risk for future cGvHD development (based upon their biomarker profile, before the onset
of cGvHD), pre-emptive therapies aimed at preventing the onset of cGvHD can be developed
based upon an individual's biological risk profile.

This study will also continue research into diagnostic biomarkers of cGvHD, and begin work
into biomarker models that predict clinical response to cGvHD therapies.
Not Available
N/A
Both
Not Available
Not Available
Kitko, Carrie
International
Vanderbilt University
08-08-2022
Other
VICCPED2183
NCT04372524

Eligibility

0 Years
BOTH
NO

To learn more about any of our clinical
trials, call 615-936-8422.